How-Wen Ko

4PUBLICATIONS

13CO-AUTHORS

Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markers

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (4)

Sort by Publication Date:

|Jun 29, 2026

Clinical characteristics and outcomes of advanced EGFR-mutated NSCLC treated with 45 or 30 mg starting doses of dacomitinib: a retrospective multicenter analysis.

|May 25, 2024

A Clinical Analysis of Anti-Programmed Death-Ligand 1 (PD-L1) Immune Checkpoint Inhibitor Treatments Combined with Chemotherapy in Untreated Extensive-Stage Small-Cell Lung Cancer.

Ping-Chih Hsu, Bing-Chen Wu, Chin-Chou Wang

|Jan 22, 2024

Differential prognostic value of tumor and plasma T790M mutations in EGFR TKI-treated advanced NSCLC.

Pi-Hung Tung, Tzu-Hsuan Chiu, Allen Chung-Cheng Huang

|Jul 27, 2022

Overall Survival Improvement in Patients with Epidermal Growth Factor Receptor-Mutated Non-Small Cell Lung Cancer and Bone Metastasis Treated with Denosumab.

How-Wen Ko, Chi-Tsun Chiu, Chih-Liang Wang

Pageof 1

Frequent Collaborators

Scott Chih-Hsi Kuo

Ping-Chih Hsu

Chin-Chou Wang

Cheng-Ta Yang

Tsung-Ying Yang

Muh-Hwa Yang

Bing-Chen Wu

Li-Chung Chiu

Chiung-Hsin Chang

Chiao-En Wu

Frequent Collaborators

Scott Chih-Hsi Kuo

Ping-Chih Hsu

Chin-Chou Wang

Cheng-Ta Yang